<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35593">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02643199</url>
  </required_header>
  <id_info>
    <org_study_id>5D Echocardiography</org_study_id>
    <nct_id>NCT02643199</nct_id>
  </id_info>
  <brief_title>Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy</brief_title>
  <official_title>Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study to evaluate Five-Dimensional Ultrasound in automated assessment of the
      fetal heart from 34-36 weeks of gestation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Prospective pilot study that will be performed at the Fetal Care Unit at Ain Shams
      University Maternity Hospital.

      Ninety pregnant women will be recruited from the Fetal Care Unit who will fulfill the
      inclusion criteria. They will be counseled to be included into the study.

      All cases will be subjected to:

        1. Full history taking including patient's age, parity, last menstrual period, estimated
           gestational age by dates, past history of medical disorders, clinical examinations
           (General and abdominal).

        2. Two-Dimensional Ultrasound and Five-Dimensional Ultrasound will be done for all cases
           for assessment of fetal Heart.

             -  90 consecutive patients will undergo 2D fetal echocardiography by one observer

             -  Then they will undergo blindly Five-Dimensional fetal echocardiography by another
                observer

             -  The data collected will be compared to evaluate the accuracy of Five-Dimensional
                US in fetal heart assessment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>folliclulometry by Five-Dimensional Ultrasound and Two-Dimensional Ultrasound measurement In controlled ovarian stimulation</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Fetal Heart Echocardiography by Five Dimensional Ultrasound</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This is a Prospective pilot study that will be performed at the Fetal Care Unit at Ain
        Shams University Maternity Hospital.

        Ninety pregnant women will be recruited from the Fetal Care Unit who will fulfill the
        inclusion criteria. They will be counseled to be included into the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Singleton pregnancy.

          2. Gestational age at 34-36 weeks as determined be date and last menstrual period.

          3. Normal Amniotic Fluid Index.

        Exclusion Criteria:

          1. Multiple pregnancies.

          2. Oligohydramnios or Polyhydramnios (AFI &gt; 95th percentile or &lt; 5th percentile).

          3. Obese patient, BMI &gt; 30

          4. Intrauterine growth restriction.

          5. Fetal spine between the 11- and 1- O'clock positions due to possibility of shadowing
             from ribs or spine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 6, 2016</lastchanged_date>
  <firstreceived_date>December 28, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Rehab Mohamed Abdelrahman</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynaecology Faculty of Medicine, Ain Shams University</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
